| Birth Day | January 27, 1965 |
| Birth Place | Belgium |
| Age | 59 YEARS OLD |
| Birth Sign | Aquarius |
| Education | pharmocology at University of Ghent, General Management at Vlerick Leuven Gent Management School |
| Occupation | Charmain of RSC Anderlecht |
Marc Coucke's net worth is projected to reach $1.2 billion by 2024, a testament to his remarkable success in the business world. A prominent figure in Belgium, Coucke is widely recognized as a key player in the healthcare industry. With his astute business acumen and relentless drive, he has made a significant impact, both locally and globally. As the founder of pharmaceutical company Omega Pharma, Coucke has revolutionized the healthcare sector through innovative solutions and strategic partnerships. His dedication to improving public health has solidified his reputation as a visionary leader in Belgium's healthcare industry.
In 1987 with Yvan Vindevogel, he founded Omega Pharma a Belgian pharmaceuticals company that grew rapidly and in 2006 employed three thousand people whilst operating in thirty countries. He remained Chief Executive Officer of Omega Pharma until 30 September 2006 returning to the post in March 2008. Whilst his Business profile represents considerable achievement there have been high publicised failures that include the launch of Omega Pharma's E-Waves phone Chip in 2008. It was withdrawn shortly after release as it did not work.
In 2007, he was featured as a member of the jury in the television show De bedenkers. In 2013 he became the major shareholder and chairman of K V Oostende. Five years later, on 20 December 2017, he bought RSC Anderlecht.
